🔴 Health ETF (ARKG) is trading 3% down amid possible profit-taking

ARKG is trading at $48.37 (-3.01%) amid possible profit-taking in high-beta genomics holdings and pre-Jackson Hole rate uncertainty.

• XLV was down about 0.43% at 9:40 AM ET, while XBI was approximately flat.
• The S&P 500 was down 0.06% and Nasdaq down 0.33%, leaving the broader market mixed.
• Revolution Medicines’ FDA approval was announced August 26 and is positive, not a clear cause of today’s decline; no confirmed ARKG-specific catalyst was identified.